| 标题 |
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Science Translational Medicine 作者:Julie R. Duffield; Xiaonan Hou; Benjamin Wilson; Anjali Prasad; Iman K. McKeon-Makki; et al 出版日期:2026-01-14 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)